XML 16 R4.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Grant revenue $ 1,939,751 $ 1,526,482 $ 7,575,972 $ 4,654,294
Operating expenses:        
Research and development 5,125,097 1,791,487 11,711,746 5,583,149
General and administrative 2,210,927 2,410,124 6,850,536 4,403,590
Total operating expenses 7,336,024 4,201,611 18,562,282 9,986,739
Loss from operations (5,396,273) (2,675,129) (10,986,310) (5,332,445)
Other income (expense):        
Other income (expense) (3,440) 4,777,824 (3,717) 5,422,192
Interest income 646,172 47,667 1,405,246 100,778
Total other income, net 642,732 4,825,491 1,401,529 5,522,970
Net (loss) income $ (4,753,541) $ 2,150,362 $ (9,584,781) $ 190,525
Net loss per share of common stock, diluted (in dollars per share) $ (0.55) $ (0.7) $ (1.22) $ (2.37)
Net (loss) income per share of common stock, basic (in dollars per share) $ (0.55) $ 0.65 $ (1.22) $ 0.13
Weighted average shares outstanding, basic (in shares) 8,702,764 3,308,302 7,861,757 1,458,415
Weighted average shares outstanding, diluted (in shares) 8,702,764 3,766,700 7,861,757 2,209,407
Comprehensive (loss) income:        
Net unrealized loss on marketable securities $ 142,864 $ 0 $ 123,162 $ 0
Total comprehensive loss $ (4,610,677) $ 2,150,362 $ (9,461,619) $ 190,525